Denali Therapeutics (DNLI) EPS (Basic) (2017 - 2026)
Denali Therapeutics' (DNLI) quarterly EPS (Basic) came in at -$0.69 in Q1 2026, up 12.89% year-on-year from -$0.61 in Q1 2025, and up 9.19% on a QoQ basis from -$0.76 in Q4 2025.
Denali Therapeutics (DNLI) EPS (Basic) (2017 - 2026) Analysis & Trends
Denali Therapeutics (DNLI) has 10 years of EPS (Basic) data on file, last reported at -$0.69 in Q1 2026.
- On a quarterly basis, EPS (Basic) rose 12.89% year-over-year to -$0.69 in Q1 2026; TTM through Mar 2026 was -$3.01, a 10.89% decrease from a year earlier, with the FY2025 full-year figure at -$2.97, down 15.49% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.69, up from -$0.76 in the prior quarter.
- Over the last five years, EPS (Basic) for DNLI reached as high as $1.34 in Q2 2023 and fell as low as -$1.0 in Q2 2025.
- Historically, EPS (Basic) has averaged -$0.61 across 5 years, with a median of -$0.72 in 2023.
- Across the five-year window, EPS (Basic) soared 379.96% in 2023 and plunged 145.1% in 2024, its largest moves.
- Year by year, EPS (Basic) stood at -$0.79 in 2022, then declined by 10.64% to -$0.87 in 2023, then advanced by 17.81% to -$0.71 in 2024, then slipped by 6.49% to -$0.76 in 2025, then grew by 9.19% to -$0.69 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$0.69 in Q1 2026, -$0.76 in Q4 2025, and -$0.75 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Denali Therapeutics | 4.33 Bn | 4.33 Bn | - | -0.69 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.69 |
| Dec 31, 2025 | -0.76 |
| Sep 30, 2025 | -0.75 |
| Jun 30, 2025 | -1.00 |
| Mar 31, 2025 | -0.79 |
| Dec 31, 2024 | -0.71 |
| Sep 30, 2024 | -0.65 |
| Jun 30, 2024 | -0.60 |
| Mar 31, 2024 | -0.70 |
| Dec 31, 2023 | -0.87 |
| Sep 30, 2023 | -0.72 |
| Jun 30, 2023 | 1.34 |
| Mar 31, 2023 | -0.83 |
| Dec 31, 2022 | -0.79 |
| Sep 30, 2022 | -0.84 |
| Jun 30, 2022 | -0.48 |
| Mar 31, 2022 | -0.56 |
| Dec 31, 2021 | -0.62 |
| Sep 30, 2021 | -0.69 |
| Jun 30, 2021 | -0.50 |